Clinical Development Archives

Ono Pharma Seeks Approval for Ripretinib in GIST Patients Japan

Business WireMarch 26, 2026March 27, 2026

by Business WireMarch 26, 2026March 27, 2026017

Ono Pharmaceutical Co., Ltd. that Ono submitted an application for the manufacturing and marketing approval of ripretinib (DCC-2618), developed by Deciphera Pharmaceuticals, Inc. (“Deciphera”), for...

Healthcare Infrastructure, Operations & Supply Chain

BeOne Medicines Launches After Move to Switzerland

Business WireMay 29, 2025August 1, 2025

by Business WireMay 29, 2025August 1, 20250365

BeOne Medicines Ltd., a global oncology company formerly known as BeiGene, Ltd., today announced its new name and redomiciliation to Switzerland are officially in effect,...

Clinical Research, Pharma & Healthcare Financing

Azafaros Raises €132M in Series B for Phase 3 Lysosomal Therapies

Business WireMay 13, 2025August 1, 2025

by Business WireMay 13, 2025August 1, 20250224

Azafaros, a clinical-stage company focused on developing disease-modifying therapeutics to offer new treatment options to patients with rare lysosomal storage disorders, announces the completion of...

Clinical Research, Pharma & Healthcare Financing

Sirius Therapeutics Raises $50M for siRNA Cardiometabolic Therapy

Business WireMay 9, 2025August 1, 2025

by Business WireMay 9, 2025August 1, 20250237

Sirius Therapeutics today announced that it has successfully completed nearly $50 million Series B2 financing to advance clinical development of the Company’s novel siRNA therapeutics...

Clinical Research, Pharma & Healthcare Financing

AN2 Therapeutics Shares Phase 3 EBO-301 Data and Future Milestones

Business WireMay 2, 2025August 1, 2025

by Business WireMay 2, 2025August 1, 20250177

EBO-301 truncated Phase 3 study (n=97) misses primary endpoint; results unable to confirm clinical efficacy observed in Phase 2 study, patients had underlying severe, advanced...

Clinical Research, Pharma & Healthcare Financing

Ray Therapeutics Gets $8M CIRM Grant for RP Gene Therapy

Business WireApril 25, 2025August 1, 2025

by Business WireApril 25, 2025August 1, 20250254

Funding will support ongoing clinical development of optogenetic therapy to restore vision Ray Therapeutics, a biotechnology company developing optogenetic gene therapies for vision restoration, today...

Clinical Research, Pharma & Healthcare Financing

Onward Therapeutics Announces IMPD Approval for OT-C001 Trial

PR NewswireApril 22, 2025August 1, 2025

by PR NewswireApril 22, 2025August 1, 20250191

Onward Therapeutics SA, a biotechnology company dedicated to advancing innovative cancer immunotherapies, announced that its subsidiary, Emercell SAS, has received Investigational Medicinal Product Dossier (IMPD)...

Clinical Research, Pharma & Healthcare Financing

Vantage Biosciences Begins Phase 2 Trial of Oral VX-01 for NPDR

GlobeNewswireApril 11, 2025August 1, 2025

by GlobeNewswireApril 11, 2025August 1, 20250199

Vantage Biosciences, a clinical stage biotechnology company advancing innovative therapies for diabetic eye diseases, today announced that the first patient has been successfully dosed in...

Clinical Research, Pharma & Healthcare Financing

Advanced Therapies Europe 2025 Debuts Curated 500-Attendee Format

PR NewswireApril 7, 2025August 1, 2025

by PR NewswireApril 7, 2025August 1, 20250230

Advanced Therapies Europe arrives in Barcelona for the first time, taking place from 2-4 September 2025 at the Hotel Arts, Ritz-Carlton. With a bold new focus, this year’s edition...

Clinical Research, Pharma & Healthcare Financing

ABL Bio Licenses Grabody-B Platform to GSK for Brain Drugs

PR NewswireApril 7, 2025August 1, 2025

by PR NewswireApril 7, 2025August 1, 20250251

ABL Bio and GSK enter into a multi-program agreement to develop novel medicines for neurodegenerative diseases Programs will leverage ABL Bio’s Grabody-B platform technology to effectively deliver molecules across...

Clinical Research, Pharma & Healthcare Financing

BeiGene Ends Ociperlimab Clinical Program Following Futility Analysis

Business WireApril 4, 2025August 1, 2025

by Business WireApril 4, 2025August 1, 20250248

BeiGene, Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne Medicines Ltd., today announced the...

Clinical Research, Pharma & Healthcare Financing

Infinitopes Adds Two Biotech Leaders to Board for Immunotherapies

PR NewswireMarch 20, 2025August 1, 2025

by PR NewswireMarch 20, 2025August 1, 20250244

Infinitopes, a pioneering precision immuno-oncology company, today announced the appointments of Dan Menichella and Jo Brewer, PhD as Non-Executive Directors to its Board as the company prepares to...

Workforce Development & Leadership

Xeltis Adds Leading Experts to Medical Advisory Board

PR NewswireMarch 11, 2025August 1, 2025

by PR NewswireMarch 11, 2025August 1, 20250255

Leading nephrologists Dr. An De Vriese and Dr. Monnie Wasse join as Company continues clinical advancement Xeltis, a leading developer of transformative implants that enable the natural...

Tag : clinical development

Ono Pharma Seeks Approval for Ripretinib in GIST Patients Japan

BeOne Medicines Launches After Move to Switzerland

Azafaros Raises €132M in Series B for Phase 3 Lysosomal Therapies

Sirius Therapeutics Raises $50M for siRNA Cardiometabolic Therapy

AN2 Therapeutics Shares Phase 3 EBO-301 Data and Future Milestones

Ray Therapeutics Gets $8M CIRM Grant for RP Gene Therapy

Onward Therapeutics Announces IMPD Approval for OT-C001 Trial

Vantage Biosciences Begins Phase 2 Trial of Oral VX-01 for NPDR

Advanced Therapies Europe 2025 Debuts Curated 500-Attendee Format

ABL Bio Licenses Grabody-B Platform to GSK for Brain Drugs

BeiGene Ends Ociperlimab Clinical Program Following Futility Analysis

Infinitopes Adds Two Biotech Leaders to Board for Immunotherapies

Xeltis Adds Leading Experts to Medical Advisory Board

Cotiviti Showcases Health Enablement at RISE 2026

Women Leaders Shape the Future of Residential Real...

BOMA Launches Canvassing for New Mixed-Use Properties Standard

NUBURU Launches U.S. Defense Manufacturing Phase I

Apex Commercial Exchange Launches AI-Powered CRE Mobile App

Quick Links

Stay up to date